✦ LIBER ✦

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma

✍ Scribed by S. T. Holgate; A. G. Chuchalin; J. Hébert; J. Lötvall; G. B. Persson; K. F. Chung; J. Bousquet; H. A. Kerstjens; H. Fox; J. Thirlwell; G. Della Cioppa; on behalf of the Omalizumab 011 International Study Group

Book ID: 108687338
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 195 KB
Volume: 34
Category: Article
ISSN: 0954-7894
DOI: 10.1111/j.1365-2222.2004.1916.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of anti-immunoglobulin E therapy

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection

✍ A. A. Cruz; F. Lima; E. Sarinho; G. Ayre; C. Martin; H. Fox; P. J. Cooper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

The efficacy and safety of a third anti-

The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn’s disease after failure of two other anti-TNF antibodies

✍ M. ALLEZ; S. VERMEIRE; N. MOZZICONACCI; P. MICHETTI; D. LAHARIE; E. LOUIS; M.-A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Stability, efficacy, and safety of conti

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia

✍ U. MARTINOWITZ; J. LUBOSHITZ; D. BASHARI; B. RAVID; E. GORINA; L. REGAN; H. STAS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB